Supreme Court Denies Cert in $100 Million Novartis Pharma Sales Rep Overtime Class Action

Despite an apparent circuit split on whether drug company sales reps are entitled to overtime, the Supreme Court has let stand an appellate ruling permitting a 2,700-plaintiff class action against Novartis to proceed.

By |2011-03-23T00:30:39+00:00March 23rd, 2011|Uncategorized|Comments Off on Supreme Court Denies Cert in $100 Million Novartis Pharma Sales Rep Overtime Class Action